Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.53 USD | +0.66% | +11.68% | +73.86% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 14.34 | 37.11 | 202.6 | 66.92 | 110.3 | 191.7 | - | - |
Enterprise Value (EV) 1 | 14.34 | 37.11 | 202.6 | 66.92 | 110.3 | 191.7 | 191.7 | 191.7 |
P/E ratio | -0.77 x | -0.48 x | -8.89 x | -2.52 x | -3.67 x | -5.72 x | -5.16 x | 6.65 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | - | 2.05 x |
EV / Revenue | - | - | - | - | - | - | - | 2.05 x |
EV / EBITDA | - | - | - | - | - | - | - | - |
EV / FCF | - | - | - | - | -5.26 x | -7.99 x | -5.33 x | -27.4 x |
FCF Yield | - | - | - | - | -19% | -12.5% | -18.8% | -3.65% |
Price to Book | - | 1.66 x | 1.47 x | 0.57 x | 1.22 x | 3.06 x | - | - |
Nbr of stocks (in thousands) | 9,131 | 39,068 | 126,624 | 126,624 | 125,304 | 125,304 | - | - |
Reference price 2 | 1.570 | 0.9500 | 1.600 | 0.5285 | 0.8800 | 1.530 | 1.530 | 1.530 |
Announcement Date | 3/26/20 | 3/31/21 | 2/28/22 | 3/22/23 | 4/1/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | 93.69 |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | -17.27 | -14.61 | -20.52 | -27.69 | -31.38 | -36.58 | -42.33 | 21.06 |
Operating Margin | - | - | - | - | - | - | - | 22.47% |
Earnings before Tax (EBT) 1 | -17.24 | -17.83 | -20.61 | -26.96 | -30.09 | -35.34 | -41.73 | 21.59 |
Net income 1 | -17.24 | -17.83 | -20.61 | -26.96 | -30.09 | -35.34 | -41.73 | 17.86 |
Net margin | - | - | - | - | - | - | - | 19.06% |
EPS 2 | -2.030 | -1.970 | -0.1800 | -0.2100 | -0.2400 | -0.2675 | -0.2967 | 0.2300 |
Free Cash Flow 1 | - | - | - | - | -20.96 | -24 | -36 | -7 |
FCF margin | - | - | - | - | - | - | - | -7.47% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/26/20 | 3/31/21 | 2/28/22 | 3/22/23 | 4/1/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -5.159 | -4.828 | -4.747 | -6.595 | -8.205 | -8.138 | -7.098 | -7.793 | -7.468 | -9.019 | -8.5 | -8.8 | -9.1 | -9.467 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -5.197 | -4.832 | -4.786 | -6.672 | -8.011 | -7.491 | -6.281 | -9.83 | -6.229 | -7.754 | -8.133 | -8.467 | -8.8 | -9.233 |
Net income 1 | -5.197 | -4.832 | -4.786 | -6.672 | -8.011 | -7.491 | -6.281 | -9.83 | -6.229 | -7.754 | -8.133 | -8.467 | -8.8 | -9.233 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.0400 | -0.0400 | -0.0400 | -0.0500 | -0.0600 | -0.0600 | -0.0500 | -0.0800 | -0.0500 | -0.0600 | -0.0633 | -0.0633 | -0.0667 | -0.0700 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/15/21 | 2/28/22 | 5/9/22 | 8/8/22 | 11/7/22 | 3/22/23 | 5/15/23 | 8/14/23 | 11/13/23 | 4/1/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | - | -21 | -24 | -36 | -7 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | 0.5700 | 1.090 | 0.9300 | 0.7200 | 0.5000 | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | 0.01 | 0.01 | - | 0.01 | 0.5 | 0.5 | 0.9 |
Capex / Sales | - | - | - | - | - | - | - | 0.96% |
Announcement Date | 3/26/20 | 3/31/21 | 2/28/22 | 3/22/23 | 4/1/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.86% | 192M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ATOS Stock
- Financials Atossa Therapeutics, Inc.